Comparison of the OSHO Protocol to a Standard Arm Protocol of the German AML Intergroup in Patients With AML>60a

NCT01497002 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1222

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukaemia

Interventions

DRUG: Cytarabine
BIOLOGICAL: human stem cells

Sponsor

University of Leipzig